Integrin activation and P-selectin expression of the non-treated ITP platelets (either acute/persistent or chronic) in response to stimulation was greater than that of romiplostim-treated group or healthy children (Fig. 1G,H). The gene discussed is SELP; the disease is autoimmune thrombocytopenic purpura.